Navigation Links
Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
Date:1/24/2008

including the price of the Company's shares, the uncertainties related to the regulatory process for drug approval and the commercialization of the Company's products, if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
11. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Akorn Inc Announces Third Quarter 2009 Earnings Release and Conference Call Information 60113 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 2Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 3Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 4Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 5Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 6Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 7Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 8Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 9Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 10Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 11Medivation to Host Conference Call at 8 3A30 a m Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100 14596 1